JACOB LASALLE: Open Payments
NPI 1669883484 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 30 payments from 10 companies in 2025. Trend: 2023 $478 · 2024 $411 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 6 | $194 |
| ABBVIE INC. | 7 | $162 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $113 |
| Ipsen Biopharmaceuticals, Inc | 2 | $55 |
| Merz Pharmaceuticals, LLC | 1 | $46 |
| Bioventus LLC | 2 | $44 |
| Valinor Pharma, LLC | 2 | $38 |
| Forte Bio-Pharma LLC | 1 | $27 |
| DePuy Synthes Sales Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
Products named: Senza, RELISTOR, UBRELVY, Dysport, BOTOX, Xeomin, QULIPTA, MOVANTIK.
Industry payments across NY — which companies pay providers there.
